Akebia Therapeutics Inc Conference Call and Live Webcast to Discuss the PRO(2)TECT Data Transcript
Welcome to Akebia Therapeutics PRO2TECT top line data readout call. As a reminder, this call is being recorded. I would now like to introduce your host for today's conference, Kristen Sheppard.
Thank you, and good morning. My name is Kristen Sheppard, Senior Vice President of Investor Relations of Akebia. Thank you for joining us to discuss Akebia's top line data from PRO2TECT, the second of our 2 global Phase III cardiovascular outcomes program, evaluating vadadustat for the treatment of anemia due to chronic kidney disease.
We issued a press release containing this top line data this morning. It is also available on our Investor Relations website, along with the slides for today's call. For your convenience, an audio replay of today's call and the slides will also be available on our website shortly after we conclude today's webcast.
Joining our call today are John Butler, our President and Chief Executive Officer, and Dr. Steven Burke, our Chief Medical Officer.
Before we
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |